ConductScience.org, home

Paper36136557

Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches.

Kępczyńska K and 1 other. Toxins (Basel), 2022. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches. Papers, record 36136557. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36136557

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches.
PubMed
Journal
Toxins (Basel)
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
2.23
iCite
Revised in PubMed
2022-10-14
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kępczyńska KKatarzyna
2Domitrz IIzabelahttps://orcid.org/0000-0003-3130-1036

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Botulinum Toxins, Type AMajor topic
Migraine DisordersMajor topic
Neuromuscular AgentsMajor topic
Tension-Type HeadacheMajor topic
Calcitonin Gene-Related Peptide
Glutamates
Headache
Humans
Quality of Life
SNARE Proteins
Substance P
Treatment Outcome

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117547312Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial.Aviat Space Environ Med2007https://conductscience.org/library/papers/17547312PubMed
212011271Diagnostic lessons from the spectrum study.Neurology2002https://conductscience.org/library/papers/12011271PubMed
326232105Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic cluster headache.Cephalalgia2016https://conductscience.org/library/papers/26232105PubMed
415836567Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.Headache2005https://conductscience.org/library/papers/15836567PubMed
534090319The efficacy of botulinum toxin A treatment for tension-type or cervicogenic headache: a systematic review and meta-analysis of randomized, placebo-controlled trials.Scand J Pain2021https://conductscience.org/library/papers/34090319PubMed
633008506OnabotulinumtoxinA injection in the treatment of chronic migraine.Prog Brain Res2020https://conductscience.org/library/papers/33008506PubMed
730522135Migraine and Tension-Type Headache.Semin Neurol2018https://conductscience.org/library/papers/30522135PubMed
835906722Temporomandibular disorders and neck pain in primary headache patients: a retrospective machine learning study.Acta Odontol Scand2023https://conductscience.org/library/papers/35906722PubMed
933348571Botulinum Toxin in the Treatment of Headache.Toxins (Basel)2020https://conductscience.org/library/papers/33348571PubMed
1024915026Botulinum toxin A, brain and pain.Prog Neurobiol2014https://conductscience.org/library/papers/24915026PubMed
1124819339Therapeutic use of botulinum toxin in migraine: mechanisms of action.Br J Pharmacol2014https://conductscience.org/library/papers/24819339PubMed
1222275844Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.Neuropsychiatr Dis Treat2012https://conductscience.org/library/papers/22275844PubMed
1333726534The Secondary Headaches.Cephalalgia2021https://conductscience.org/library/papers/33726534PubMed
1429368949Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.Cephalalgia2018https://conductscience.org/library/papers/29368949PubMed
1527844455GBD 2015: migraine is the third cause of disability in under 50s.J Headache Pain2016https://conductscience.org/library/papers/27844455PubMed
1631563224Migraine: Epidemiology, Burden, and Comorbidity.Neurol Clin2019https://conductscience.org/library/papers/31563224PubMed
1720647171OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.Cephalalgia2010https://conductscience.org/library/papers/20647171PubMed
1822535858Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.JAMA2012https://conductscience.org/library/papers/22535858PubMed
1917040331Modifiable risk factors for migraine progression.Headache2006https://conductscience.org/library/papers/17040331PubMed
2029493566Cluster headache.Nat Rev Dis Primers2018https://conductscience.org/library/papers/29493566PubMed

See all 32 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42784323Adjunctive Use of Botulinum Toxin in Orthognathic Surgery: A Systematic Review of Current Evidence and Clinical Perspectives.Toxins (Basel)2026https://conductscience.org/library/papers/42784323PubMed
42784282One Molecule, Different Circuits? What Botulinum Toxin Can and Cannot Reveal About Craniocervical Comorbidity.Toxins (Basel)2026https://conductscience.org/library/papers/42784282PubMed
42347502Botulinumtoxin Type-A (BoNTA) in the Management of Refractory Trigeminal Neuralgia: An Expert-Opinion, Practice-Oriented Narrative Review on Behalf of the GRASP Study Group.Toxins (Basel)2026https://conductscience.org/library/papers/42347502PubMed
41709680Post-Botulinum Headache in Cosmetic Practice: A Prospective Study.J Cosmet Dermatol2026https://conductscience.org/library/papers/41709680PubMed
41682889Neurochemical Changes Following Botulinum Toxin Type A in Chronic Migraine: An LC-MS/MS and HPLC Evaluation of Plasma and Urinary Biomarkers.J Clin Med2026https://conductscience.org/library/papers/41682889PubMed
41607435Sustained anxiolytic and antidepressant effects of botulinum toxin A in blepharospasm patients beyond motor symptom control.World J Psychiatry2026https://conductscience.org/library/papers/41607435PubMed
40142828Botulinum Toxin Therapy: A Comprehensive Review on Clinical and Pharmacological Insights.J Clin Med2025https://conductscience.org/library/papers/40142828PubMed
39984566Intradermally injected abobotulinumtoxinA administered preemptively before surgery alleviates post-surgical pain and normalizes behavior in a translational animal model.Sci Rep2025https://conductscience.org/library/papers/39984566PubMed
39453207Non-Migraine Head Pain and Botulinum Toxin.Toxins (Basel)2024https://conductscience.org/library/papers/39453207PubMed
39227336Treatment Patterns and Persistence Among Patients Newly Diagnosed With Migraine in South Korea: A Retrospective Analysis of Health Claims Data.J Clin Neurol2024https://conductscience.org/library/papers/39227336PubMed
38962481The effectiveness and predictors influencing the outcome of onabotulinumtoxinA treatment in chronic migraine: understanding from diverse patient profiles in a single session.Front Neurol2024https://conductscience.org/library/papers/38962481PubMed
38839615Evaluation of the Effect of Botulinum Toxin A on the Lymphatic Endothelial Cells.Aesthetic Plast Surg2024https://conductscience.org/library/papers/38839615PubMed
38672000Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort.Brain Sci2024https://conductscience.org/library/papers/38672000PubMed
37235358Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.Toxins (Basel)2023https://conductscience.org/library/papers/37235358PubMed
37090974Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study.Front Neurol2023https://conductscience.org/library/papers/37090974PubMed
36983822Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review.Life (Basel)2023https://conductscience.org/library/papers/36983822PubMed
36828401A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role.Toxins (Basel)2023https://conductscience.org/library/papers/36828401PubMed
36668895Effects of Botulinum Toxin Type A on the Nociceptive and Lemniscal Somatosensory Systems in Chronic Migraine: An Electrophysiological Study.Toxins (Basel)2023https://conductscience.org/library/papers/36668895PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TAC16863PubTator's text mininghttps://conductscience.org/library/genes/6863

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36136557

GET https://conductscience.org/api/papers/v1/36136557/references?page=2